{
  "data": [
    {
      "Project Code": "R0639",
      "Project Name": "AAVF21 | AAV FGF21 - Transforming the chronic delivery of therapeutic proteins for metabolic diseases",
      "Dx Name": "Project Name4",
      "Dx Title": "AAV FGF21 - Transforming the chronic delivery of therapeutic proteins for metabolic diseasessd",
      "status": "Closed-Open4",
      "phaseCode": null,
      "category": "DRUG"
    },
    {
      "Project Code": "R0715102",
      "Project Name": "AmyRsm | Development of an oral AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "Dx Name": null,
      "Dx Title": "Development of an oral AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "status": "Active",
      "phaseCode": "TV5",
      "category": "Categorytest"
    },
    {
      "Project Code": "R0000",
      "Project Name": "AmylinR agonist small molecule allows for FDC oral small molecule therapies with the ability to have bariatric surgery-like weight loss from a well-tolerated oral therapy with end organ protection.",
      "Dx Name": null,
      "Dx Title": "Developmentof small molecule412.",
      "status": "Active",
      "phaseCode": "UNKNOWN",
      "category": "FBP"
    }
  ]
}